학술논문
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials
Document Type
Article
Author
Source
In Annals of Oncology January 2006 17(1):65-73
Subject
Language
ISSN
0923-7534